TRIM25 and breast carcinoma: Thus, we have shown that TRIM25 negatively regulates the stability of BRD7 protein through the ubiquitin-proteasome pathway, and confirmed the direct binding domains of TRIM25 and BRD7, which provide the molecular basis for further development of targeted therapy for the treatment of breast cancer.